HNRNPA1 de novo Variant Associated with Early Childhood Onset, Rapidly Progressive Generalized Myopathy

J Neuromuscul Dis. 2024;11(5):1131-1137. doi: 10.3233/JND-240050.

Abstract

HNRNPA1 variants are known to cause degenerative motoneuron and muscle diseases which manifests in middle age or later. We report on a girl with early childhood onset, rapidly progressive generalized myopathy including ultrastructural findings in line with a proteinopathy. Proteomics of patient-derived muscle and combined screening of genomic data for copy number variations identified a HNRNPA1 de novo intragenic deletion as causative for the phenotype. Our report expands the spectrum of HNRNPA1-related diseases towards early-childhood onset and adds HNRNPA1 to the growing list of ALS and myopathy genes for which certain mutations may cause severe pediatric phenotypes.

Keywords: Inclusion body myopathy; multisystem proteinopathy; muscle proteomics; neuromyopathy; proteogenomics; vacuolar myopathy.

Publication types

  • Case Reports

MeSH terms

  • Age of Onset
  • Child
  • Disease Progression
  • Female
  • Heterogeneous Nuclear Ribonucleoprotein A1* / genetics
  • Humans
  • Muscle, Skeletal / pathology
  • Muscular Diseases* / genetics
  • Mutation
  • Phenotype

Substances

  • Heterogeneous Nuclear Ribonucleoprotein A1
  • hnRNPA1 protein, human